Evidence map›Paper›PMID 28883999›Full record

ReviewFuture science OA2017

Galactofuranose antigens, a target for diagnosis of fungal infections in humans.

Carla Marino, Adriana Rinflerch, Rosa M de Lederkremer

Open access · goldAbstract readReview
In one paragraph

Review in Future science OA, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. The postbiotic potential ofFrontiers in microbiology · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. The Glycan Structure ofMolecules (Basel, Switzerland) · 2020
    Review
  8. Galactofuranose-Related Enzymes: Challenges and Hopes.International journal of molecular sciences · 2020
    Review
  9. Article
  10. Review
  11. Article
  12. Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Carla MarinoUniversidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Centro de Investigaciones en Hidratos de Carbono (CIHIDECAR), Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales, Pabellón II, Ciudad Universitaria, 1428 Ciudad Autónoma de Buenos Aires, Argentina.
Adriana RinflerchServicio de Dermatología, Dermatología Experimental, Hospital Italiano de Buenos Aires, C1199ACL, Ciudad Autónoma de Buenos Aires, Argentina.
Rosa M de LederkremerUniversidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Centro de Investigaciones en Hidratos de Carbono (CIHIDECAR), Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales, Pabellón II, Ciudad Universitaria, 1428 Ciudad Autónoma de Buenos Aires, Argentina.
Fundación Ciencias Exactas y Naturales · ARHospital Italiano de Buenos Aires · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of biomarkers for the detection of fungal infections is of interest to complement histopathological and culture methods. Since the production of antibodies in immunocompromised patients is scarce, detection of a specific antigen could be effective for early diagnosis. D-Galactofuranose (Gal

Indexed as

biomarkersdiagnosisfungal infectionsgalactofuranoseimmune responsesynthetic haptens

Identifiers

PMID28883999
PMCPMC5583699
OpenAlexW2617648033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.